Divergent antioxidant capacity of human islet cell subsets: A potential cause of beta-cell vulnerability in diabetes and islet transplantation

被引:73
|
作者
Miki, Atsushi [1 ,4 ]
Ricordi, Camillo [1 ]
Sakuma, Yasunaru [1 ,4 ]
Yamamoto, Toshiyuki [1 ,5 ]
Misawa, Ryosuke [1 ,6 ]
Mita, Atsuyoshi [1 ,6 ]
Molano, Ruth D. [1 ]
Vaziri, Nosratola D. [2 ]
Pileggi, Antonello [1 ]
Ichii, Hirohito [1 ,3 ,7 ]
机构
[1] Univ Miami, Cell Transplant Ctr, Diabet Res Inst, Miami, FL 33124 USA
[2] Univ Calif Irvine, Dept Med, Irvine, CA 92717 USA
[3] Univ Calif Irvine, Dept Surg, Irvine, CA 92717 USA
[4] Jichi Med Univ, Dept Surg, Shimotsuke, Tochigi, Japan
[5] Fujita Hlth Univ, Dept Surg, Toyoake, Aichi, Japan
[6] Shinshu Univ, Dept Surg, Matsumoto, Nagano, Japan
[7] Univ Calif Irvine, Dept Surg, Irvine, CA 92717 USA
来源
PLOS ONE | 2018年 / 13卷 / 05期
关键词
HUMAN PANCREATIC-ISLETS; LASER-SCANNING CYTOMETRY; GLUTATHIONE-PEROXIDASE; SUPEROXIDE-DISMUTASE; ALLOGRAFT-REJECTION; RADICAL SCAVENGER; OXIDATIVE STRESS; NITRIC-OXIDE; DNA-DAMAGE; MASS;
D O I
10.1371/journal.pone.0196570
中图分类号
O [数理科学和化学]; P [天文学、地球科学]; Q [生物科学]; N [自然科学总论];
学科分类号
07 ; 0710 ; 09 ;
摘要
Background Type 1 and Type 2 diabetes mellitus (T1DM and T2DM) are caused by beta(beta)-cell loss and functional impairment. Identification of mechanisms of beta-cell death and therapeutic interventions to enhance beta-cell survival are essential for prevention and treatment of diabetes. Oxidative stress is a common feature of both T1DM and T2DM; elevated biomarkers of oxidative stress are detected in blood, urine and tissues including pancreas of patients with DM. Islet transplantation is a promising treatment for diabetes. However, exposure to stress (chemical and mechanical) and ischemia-reperfusion during isolation and transplantation causes islet loss by generation of reactive oxygen species (ROS). Human intracellular antioxidant enzymes and related molecules are essential defenses against ROS. Antioxidant enzyme levels including superoxide dismutase (SOD), catalase, and glutathione peroxidase (GPX) have been shown to be low in islet cells. However, little is known about the expression and function of antioxidant enzymes within islet cell subsets. We evaluated the expression of the key antioxidant enzymes in beta- and alpha(alpha)-cell and accessed effects of oxidative stress, islet isolation and transplantation on beta/alpha-cell ratio and viability in human islets. Methods Human pancreata from T1DM, T2DM and non-diabetic deceased donors were obtained and analyzed by confocal microscopy. Isolated islets were (I) transplanted in the renal sub-capsular space of streptozotocin-induced diabetic nude mice (in vivo bioassay), or II) exposed to oxidative (H2O2) and nitrosative (NO donor) stress for 24 hrs in vitro. The ratio, % viability and death of beta- and alpha-cells, and DNA damage (8OHdG) were measured. Results and conclusions Catalase and GPX expression was much lower in beta- than alpha-cells. The beta/alpha-cell ratio fells significantly following islet isolation and transplantation. Exposure to oxidative stress caused a significantly lower survival and viability, with higher DNA damage in beta- than alpha-cells. These findings identified the weakness of beta-cell antioxidant capacity as a main cause of vulnerability to oxidative stress. Potential strategies to enhance beta-cell antioxidant capacity might be effective in prevention/treatment of diabetes.
引用
收藏
页数:16
相关论文
共 50 条
  • [1] Islet Transplantation & beta-Cell Replacement Therapies for Diabetes
    Berney, Thierry
    Korsgren, Olle
    Posselt, Andrew
    Pileggi, Antonello
    JOURNAL OF TRANSPLANTATION, 2011, 2011
  • [2] Beta-cell function and human islet transplantation: can we improve?
    Chen, Jennifer
    Gunton, Jenny E.
    JOURNAL OF ENDOCRINOLOGY, 2021, 248 (03) : R99 - R112
  • [3] Pancreatic beta-cell islet transplantation: future prospects?
    Barrou, B
    PATHOLOGIE BIOLOGIE, 1998, 46 (01): : 5 - 7
  • [4] EFFECT OF DIABETES ON ISLET AREA AND BETA-CELL FUNCTION
    BONNEVIENIELSEN, V
    LERNMARK, A
    ACTA BIOLOGICA ET MEDICA GERMANICA, 1981, 40 (01) : 77 - 81
  • [5] Evolution of beta-Cell Replacement Therapy in DiabetesMellitus: Islet Cell Transplantation
    Jahansouz, Cyrus
    Jahansouz, Cameron
    Kumer, Sean C.
    Brayman, Kenneth L.
    JOURNAL OF TRANSPLANTATION, 2011, 2011
  • [6] The Role of Necroptosis in Beta-cell Loss Following Islet Cell Transplantation
    Aggarwal, Saloni
    Kelly, Sandra
    Paramor, Joy
    Seeberger, Karen
    Rosko, Mandy
    Polishevska, Kateryna
    Kuppan, Purushothaman
    Korbutt, Gregory S.
    Pepper, Andrew R.
    TRANSPLANTATION, 2021, 105 (12) : S42 - S42
  • [7] Beta-cell function following human islet transplantation for type 1 diabetes mellitus: Preliminary results
    Rickels, MR
    Schutta, MH
    Markmann, JF
    Barker, CF
    Naji, A
    Teff, KL
    DIABETES, 2004, 53 : A36 - A36
  • [8] INTRATHYMIC ISLET CELL TRANSPLANTATION REDUCES BETA-CELL AUTOIMMUNITY AND PREVENTS DIABETES IN NOD/LT MICE
    GERLING, IC
    SERREZE, DV
    CHRISTIANSON, SW
    LEITER, EH
    DIABETES, 1992, 41 (12) : 1672 - 1676
  • [9] The Two Faces of Protein Palmitoylation in Islet beta-Cell Function: Potential Implications in the Pathophysiology of Islet Metabolic Dysregulation and Diabetes
    Mohammed, Abiy M.
    Chen, Fei
    Kowluru, Anjaneyulu
    RECENT PATENTS ON ENDOCRINE METABOLIC & IMMUNE DRUG DISCOVERY, 2013, 7 (03) : 203 - 212
  • [10] ISLET CELL TRANSPLANTATION AND DIABETES
    ELOY, R
    HAFFEN, K
    KEDINGER, M
    MICHEL, F
    BOUCHET, P
    GRENIER, JF
    NOUVELLE PRESSE MEDICALE, 1979, 8 (14): : 1171 - 1176